Probucol nitro-derivatives

Details Probucol nitro-derivatives Probucol nitro-derivatives

2007-01-23

2007-01-23

Page, Thurman (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S509000, C514S706000, C544S399000, C568S064000, C424S043000, C424S046000, C424S400000, C424S424000, C424S436000, C424S449000, C424S450000, C424S451000, C424S464000, C424S489000

Reexamination Certificate

active

10503128

ABSTRACT:
Probucol derivatives and pharmaceutical compositions containing the same to be employed in treatment or prophylaxis of diseases.

REFERENCES:
patent: 4985465 (1991-01-01), Hendler
patent: 5262439 (1993-11-01), Parthasarathy
patent: 6121319 (2000-09-01), Somers
patent: 2 140 769 (1973-01-01), None
patent: 2 140 771 (1973-01-01), None
patent: 2 168 137 (1973-08-01), None
patent: WO 9831225 (1998-07-01), None
patent: WO 9842327 (1998-10-01), None
patent: WO 98/51289 (1998-11-01), None
patent: WO 9851662 (1998-11-01), None
patent: WO 99/24400 (1999-05-01), None
patent: WO 2000028332 (2000-05-01), None
patent: WO 01/77072 (2001-04-01), None
patent: WO 01/70757 (2001-09-01), None
Zimetbaum et al., “Probucol: Pharmacology and Clinical Application”,J. Clin. Pharmacol. 30, 3-9, 1990.
Kaul et al., “Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy”,Mol. Cell. Bichem, 160/161, 283-288, 1996.
Regnström et al., “The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis”,Atheroscloerosis125, 217-229, 1996.
Lee et al., “Effectiveness of Probucol in Preventing Restenosis after Percutaneous Transluminal Coronary Angioplasty”,Jpn. Heart J. 37(3) 327-332, 2002.
Ishizaki et al., “Effect of probucol, an oral hypocholesterolaemic agent, on acute tobacco smoke inhalation in rats”,Clinical Sci. 90, 517-523, 1996.
Heel et al., “Probucol: A Review of its Pharmacological Properties and Therapeutic Use in Patients with Hypercholesterolaemia”,Drugs15, 409-428, 1978.
Reinoehl et al., “Probucol-associated tachyarrhythmic events and QT prolongatrion: Importance of gender”Am. Heart J. 131(6), 1184-1191, 1992.
Steinberg et al., “Beyond Cholesterol: Modifications of Low-Density Lipoprotein That Increase Its Atherogenicity”,New Eng. J. Med. 320(14), 915-924, 1989.
Heeg et al., “Taux plasmatiques du probucol chez l'homme aprés administration orale unique ou repetee”, Nouv. Presse Med. 9(40), 2990-2994, 1980.

Affiliated with

Also associated with

Rating

Probucol nitro-derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Probucol nitro-derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Probucol nitro-derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3807373